295 related articles for article (PubMed ID: 3259295)
1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
German DC; Dubach M; Askari S; Speciale SG; Bowden DM
Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
[TBL] [Abstract][Full Text] [Related]
2. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
3. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
[TBL] [Abstract][Full Text] [Related]
4. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
German DC; Manaye KF; Sonsalla PK; Brooks BA
Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
Schneider JS; Yuwiler A; Markham CH
Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
[TBL] [Abstract][Full Text] [Related]
6. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Herrero MT; Perez-OtaƱo I; Oset C; Kastner A; Hirsch EC; Agid Y; Luquin MR; Obeso JA; Del Rio J
Neuroscience; 1993 Oct; 56(4):965-72. PubMed ID: 7904332
[TBL] [Abstract][Full Text] [Related]
7. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
Burns RS; Markey SP; Phillips JM; Chiueh CC
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
[TBL] [Abstract][Full Text] [Related]
8. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
[TBL] [Abstract][Full Text] [Related]
9. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
Neurosci Lett; 1985 Oct; 61(1-2):195-200. PubMed ID: 3878482
[TBL] [Abstract][Full Text] [Related]
10. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
Masilamoni GJ; Groover O; Smith Y
Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Waters CM; Hunt SP; Jenner P; Marsden CD
Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
Lavoie B; Parent A
Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P
Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418
[TBL] [Abstract][Full Text] [Related]
14. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.
German DC; Manaye K; Smith WK; Woodward DJ; Saper CB
Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827
[TBL] [Abstract][Full Text] [Related]
15. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
Manaye KF; Sonsalla PK; Barnett G; Heikkila RE; Woodward DJ; Smith WK; German DC
Brain Res; 1989 Jul; 491(2):307-15. PubMed ID: 2765888
[TBL] [Abstract][Full Text] [Related]
17. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
[TBL] [Abstract][Full Text] [Related]
18. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
[TBL] [Abstract][Full Text] [Related]
19. Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.
Hantraye P; Varastet M; Peschanski M; Riche D; Cesaro P; Willer JC; Maziere M
Neuroscience; 1993 Mar; 53(1):169-78. PubMed ID: 8469305
[TBL] [Abstract][Full Text] [Related]
20. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
Imai H; Nakamura T; Endo K; Narabayashi H
Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]